| 1 |
宋勇，姚艳雯. 肺部小结节的诊断和治疗近况[J/CD]. 中华肺部疾病杂志(电子版), 2012, 5(4): 295-299.
|
| 2 |
Wahidi MM, Govert JA, Goudar RK, et al. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer? ACCP evidence-based clinical practice guidelines (2nd edition)[J]. Chest, 2007，132(3 Suppl): 94S-107S.
|
| 3 |
Austin JH, Müller NL, Friedman PJ, et al. Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society[J]. Radiology. 1996 Aug, 200(2): 327-331.
|
| 4 |
Ost D, Fein AM, Feinsilver SH. Clinicalpractice. The solitary pulmonary nodule[J]. N Engl J Med, 2003, 348(25): 2535-2542.
|
| 5 |
Hansell DM, Bankier AA, Macmahon H, et al. Fleischner society: glossary of terms for thoracic imaging[J]. Radiology, 2008, 246(3): 697-722.
|
| 6 |
National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening[J]. N Engl J Med, 2011, 365(5): 395-409.
|
| 7 |
Pastorino U, Bellomi M, Landoni C, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results[J]. Lancet, 2003, 362(9384): 593-597.
|
| 8 |
Yilmaz F, Tastekin G. Sensitivity of 18F-FDG PET in evaluation of solitary pulmonary nodules[J]. Int J Clin Exp Med, 2015, 8(1): 45-51.
|
| 9 |
Heyneman LE, Patz EF. PET imaging in patients with bronchioloalveolar cell carcinoma[J] . Lung Cancer, 2002, 38(3): 261-266.
|
| 10 |
Yap CS, Schiepers C, Fishbein MC, et al. FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma？[J]. Eur J Nucl Med Mol Imaging, 2002, 29(9): 1166-1173.
|
| 11 |
Casali C, Cucca M, Rossi G, et al. The variation of prognostic signifi cance of maximum standardized uptake value of [18 F]-fluoro-2-deoxy-glucose positron emission tomography in different histological subtypes and pathological stages of surgically resected Non-Small Cell Lung Carcinoma [J]. Lung Cancer, 2010, 69(2): 187-193 .
|
| 12 |
Okada M, Tauchi S, Iwanaga K, et al. Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic fi ndings, and malignant behavior in small lung adenocarcinomas[J] . J Thorac Cardiovasc Surg, 2007, 133(6): 1448-1454.
|
| 13 |
Lee HY, Han J, Lee KS, et al. Lung adenocarcinoma as a solitary pulmonary nodule: prognostic determinants of CT, PET, and histopathologic fi ndings[J]. Lung Cancer, 2009, 66(3): 379-385.
|
| 14 |
Cronin P, Dwamena BA, Kelly AM, et al. Solitary pulmonary nodules：meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy [J]. Radiology, 2008, 246(3): 772-782.
|
| 15 |
Tan BB, Flaherty KR, Kazerooni EA, et al. The solitary pulmonary nodule[J]. Chest, 2003, 123(1 suppl 1): 89S-96S.
|
| 16 |
Dietlein M, Weber K, Gandjour A, et al. Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany[J]. Eur J Nucl Med, 2000, 27(10): 1441-1456.
|
| 17 |
Gould MK, Sanders GD, Barnett PG, et al. Cost-effectiveness of alternative management strategiesfor patients with solitary pulmonary nodules[J]. Ann Intern Med, 2003, 138(9): 724-735.
|
| 18 |
Deppen SA, Grogan EL. Using clinical risk models for lung nodule classification[J]. Semin Thorac Cardiovasc Surg, 2015, 27(1): 30-35.
|
| 19 |
Swensen SJ, Silverstein MD, Ilstrup DM, et al. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules[J]. Arch Intern Med, 1997, 157(8): 849-855.
|
| 20 |
Gould MK, Ananth L, Barnett PG, et al. A clinical model to estimate the pre-test probability of lung cancer in patients with solitary pulmonary nodules[J]. Chest, 2007，131(2): 383-388.
|
| 21 |
McWilliams A, Tammemagi MC, Mayo JR, et al. Probability of cancer in pulmonary nodules detected on first screening CT[J]. N Engl J Med, 2013, 369(10): 910-919.
|
| 22 |
Xiao F, Liu D, Guo Y, et al. Novel and convenient method to evaluate the character of solitary pulmonary nodule-comparison of three mathematical prediction models and further stratification of risk factors[J]. PLoS One, 2013, 8(10): e78271.
|
| 23 |
Herder GJ, van Tinteren H, Golding RP, et al. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography[J]. Chest, 2005, 128(4): 2490-2496.
|
| 24 |
Al-Ameria A, Malhotrab P, Thygesenc H. Risk of malignancy in pulmonary nodules: A validation study of fourprediction models[J]. Lung Cancer, 2015, 89(1): 27-30.
|
| 25 |
Bai C, Choi CM, Chu CM, et al. Evaluation of pulmonary nodules: clinical practice consensus guidelines for Asia[J]. Chest, 2016, 150(4): 877-893.
|
| 26 |
Ru Zhao Y, Xie X, de Koning HJ, et al. NELSON lung cancer screening study[J]. Cancer Imaging, 2011, 11: S79-S84.
|
| 27 |
Tanner NT, Aggarwal J, Gould MK, et al. Management of pulmonary nodules by community pulmonologist: A multicenter observation study[J]. Chest, 2015, 148(6): 1405-1414.
|
| 28 |
Gould MK，Donington J, Lynch WR, et al. Evaluation of individuals with pulmonary nodules: When is it lung cancer: diagnosis and management of lung cancer, 3rd ed: american college of chest physicians evidence-based clinical practice guidelines[J]. Chest, 2013, 143(5 Suppl): e93S-e120S.
|
| 29 |
MacMahon H, Naidich DP, Goo JM, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: from the fleischner society 2017[J]. Radiology, 2017, 284(1): 228-243.
|
| 30 |
Kothary N, Lock L, Sze DY, et al. Computed tomography-guided percutaneous needle biopsy of pulmonary nodules: impact of nodule size on diagnostic accuracy[J]. Clin Lung Cancer, 2009, 10(5): 360-363.
|
| 31 |
Shimizu K, Ikeda N, Tsuboi M, et al. Percutaneous CT-guided fi ne needle aspiration for lung cancer smaller than 2 cm and revealed by ground-glass opacity at CT[J] . Lung Cancer, 2006, 51(2): 173-179.
|
| 32 |
Kim TJ, Lee JH, Lee CT, et al . Diagnostic accuracy of CT-guided core biopsy of ground-glass opacity pulmonary lesions[J]. AJR Am J Roentgenol, 2008, 190(1): 234-239.
|
| 33 |
Infante M, Lutman RF, Imparato S, et al. Differential diagnosis and management of focal ground-glass opacities[J]. Eur Respir J, 2009, 33(4): 821-827.
|
| 34 |
Paone G, Nicastri E, Lucantoni G, et al. Endobronchial ultrasound-driven biopsy in the diagnosis of peripheral lung lesions[J]. Chest, 2005, 128(5): 3551-3557.
|
| 35 |
Roth K, Eagan TM, Andreassen AH, et al. A randomized trial of endobronchial ultrasound guided sampling in peripheral lung lesions[J]. Lung Cancer, 2011, 74(2): 219- 225.
|
| 36 |
Schwarz Y, Greif J, Becker HD, et al. Real-time electromagnetic navigation bronchoscopy to peripheral lung lesions using overlaid CT images: the fi rst human study[J] . Chest, 2006, 129(4): 988-994.
|
| 37 |
Gildea TR, Mazzone PJ, Karnak D, et al. Electromagnetic navigation diagnostic bronchoscopy: a prospective study [J]. Am J Respir Crit Care Med, 2006, 174(9): 982-989.
|
| 38 |
Eberhardt R, Anantham D, Ernst A, et al. Multimodality bronchoscopic diagnosis of peripheral lung lesions: a randomized controlled trial[J]. Am J Respir Crit Care Med, 2007, 176(1): 36-41.
|
| 39 |
Mehta HJ, Ravenel JG, Shaftman SR, et al. The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules[J]. Chest, 2014, 145(3): 464-472.
|
| 40 |
Van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning[J]. N Engl J Med, 2009, 361(23): 2221-2229.
|
| 41 |
Ishii H1, Hiraki T, Gobara H, et al. Risk factors for systemic air embolism as a complication of percutaneous CT-guided lung biopsy: multicenter case-control study[J]. Cardiovasc Intervent Radiol, 2014, 37(5): 1312-1320.
|
| 42 |
Hiraki T, Mimura H, Gobara H, et al. CT fluoroscopyguided biopsy of 1000 pulmonary lesions performed with 20-gauge coaxial cutting needles: diagnostic yield and risk factors for diagnostic failure[J]. Chest, 2009, 136(6): 1612-1617.
|
| 43 |
Li XJ, Hayward C, Fong PY, et al. A blood-based proteomic classifier for the molecular characterization of pulmonary nodules[J]. Sci Transl Med, 2013, 5(207): 207ra142.
|
| 44 |
Pecot CV, Li M, Zhang XJ, et al. Added value of a serum proteomic signature in the diagnostic evaluation of lung nodules[J]. Cancer Epidemiol Biomarkers Prev, 2012, 21(5): 786-792.
|
| 45 |
Mazzone PJ. Analysis of volatile organic compounds in the exhaled breath for the diagnosis of lung cancer[J]. J Thorac Oncol, 2008, 3(7): 774-780.
|